Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Dietetic-led cognitive-behavioral therapy may improve treatment for adults with ARFID.

Most patients improved with oral contraceptives, but some needed additional treatment.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Pranlukast and mirabegron may work as new diabetes drugs.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

RNase L suppresses regeneration in mammals.

Topiramate impairs gene transmission in zebrafish, while Ginkgo biloba reduces harmful effects of high β-catenin levels.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Thevetia peruviana bark extract reduces pain in mice and may help create new painkillers.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Allopregnanolone, a progesterone metabolite, helps reduce restraint effects on behavior.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Bicalutamide may help treat female pattern hair loss.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Acyclovir can prevent rejection of skin grafts in herpes-related lip leucoderma.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Tamoxifen effectively treats gynecomastia without causing impotence.